AMP-activated protein kinase phosphorylates cardiac troponin I and alters contractility of murine ventricular myocytes.
about
Gene regulation, alternative splicing, and posttranslational modification of troponin subunits in cardiac development and adaptation: a focused reviewIntegration of troponin I phosphorylation with cardiac regulatory networksTNNI1, TNNI2 and TNNI3: Evolution, regulation, and protein structure-function relationships.Sexually dimorphic myofilament function and cardiac troponin I phosphospecies distribution in hypertrophic cardiomyopathy miceCombined troponin I Ser-150 and Ser-23/24 phosphorylation sustains thin filament Ca(2+) sensitivity and accelerates deactivation in an acidic environment.Stable, covalent attachment of laminin to microposts improves the contractility of mouse neonatal cardiomyocytes.Targeted deletion of PTEN in cardiomyocytes renders cardiac contractile dysfunction through interruption of Pink1-AMPK signaling and autophagyLKB1/Mo25/STRAD uniquely impacts sarcomeric contractile function and posttranslational modification.Small molecule adenosine 5'-monophosphate activated protein kinase (AMPK) modulators and human diseasesAMPK deficiency in cardiac muscle results in dilated cardiomyopathy in the absence of changes in energy metabolism.Embryonic expression of AMPK γ subunits and the identification of a novel γ2 transcript variant in adult heartAlpha1 catalytic subunit of AMPK modulates contractile function of cardiomyocytes through phosphorylation of troponin I.Functional phosphorylation sites in cardiac myofilament proteins are evolutionarily conserved in skeletal myofilament proteinsLiver Kinase B1 complex acts as a novel modifier of myofilament function and localizes to the Z-disk in cardiac myocytesThe Modulation of Cardiac Contractile Function by the Pharmacological and Toxicological Effects of Urocortin2.Arginine deiminase resistance in melanoma cells is associated with metabolic reprogramming, glucose dependence, and glutamine addiction.Localisation of AMPK γ subunits in cardiac and skeletal musclesMyofilament Calcium Sensitivity: Mechanistic Insight into TnI Ser-23/24 and Ser-150 Phosphorylation Integration.A network-based approach for predicting Hsp27 knock-out targets in mouse skeletal muscles.Clinical Spectrum of PRKAG2 Syndrome.Cardiac troponin structure-function and the influence of hypertrophic cardiomyopathy associated mutations on modulation of contractility.Contribution of Post-translational Phosphorylation to Sarcomere-Linked Cardiomyopathy Phenotypes.Targeting the energy guardian AMPK: another avenue for treating cardiomyopathy?Metabolic remodelling in hypertrophied and failing myocardium: a review.Comprehensive Characterization of AMP-Activated Protein Kinase Catalytic Domain by Top-Down Mass SpectrometryApplication of Oncology Research to Resolve a Problem in Neurourology.The art of the deal in myofilament modulation of function.The continuing evolution of cardiac troponin I biomarker analysis: from protein to proteoform.Right Ventricular Myofilament Functional Differences in Humans with Systemic Sclerosis-associated versus Idiopathic Pulmonary Arterial Hypertension.Storage diseases with hypertrophic cardiomyopathy phenotype
P2860
Q21129229-A623A9DF-E289-4B1D-872F-2BFF630D6E0BQ26852120-1B1D5B0E-2785-422D-A93A-FF864C986C9EQ30380968-32FE290D-1DAA-43BF-8D24-DC15A8F263BFQ30539357-248CFC89-85C4-49D9-A501-332B115BA223Q33821210-04F88628-2090-4E71-BA58-0839011C09F7Q34160414-803A51ED-1AB6-4CF8-87CC-7D033D643277Q34778935-AF900C56-C53A-45A2-81F6-1E9A2DA3D7D5Q35221451-4BD8C51B-DB62-4163-9FFC-9D1F0141AC02Q35224775-C3A0B0EA-59EF-4756-BAB1-1C0EDD646BDDQ36048973-76C09B56-1DA8-4559-86A2-FE4BD20DB8D5Q36335911-393ED281-FFDA-4E15-A62E-E2E33606D489Q36649084-BA7EEBF3-485B-47B9-AA85-1634073EB957Q36965797-64B9BF79-4697-4769-BE80-50CDB7D69A9EQ36984254-75DAA0B2-DD1D-4FA7-AF04-48681826C0B4Q37228131-B3F82317-CD03-4386-9E45-181BECC72103Q37339881-4DA93C7F-9A3A-4499-AA42-CD5E84926E59Q37368921-59644DA3-DA30-487B-BC3D-C10C95CF40F3Q37503779-A7BA350E-427B-462B-AE99-F18B9F5C704BQ37654998-F5BF55A6-AFA2-4CCB-9FF0-9C5A4A9BBF1EQ38686608-8C72956F-E399-4881-A172-E70334B2B1D2Q38724869-90B792C8-BD2E-400D-B9A2-EA9493EBA4E9Q38816583-926DA8B6-6839-4120-BDC1-4EA6929CE185Q38999231-DB3502C7-1675-4180-A003-F80587E87BA3Q39395331-31267171-53B0-44D2-9596-0994EAE10A28Q40406207-9091BD73-57BA-4E32-9465-4C7CC96CD65FQ41460369-3306C3C7-894F-4474-BC4C-9598C3530FB6Q43100735-622A29D9-BC06-4B05-96D6-79297B14ADF4Q47687870-C4A6D910-4A0D-46B2-BED8-A7C77183FBE4Q49911726-3FFF4A85-4D99-48C7-9B48-F2131C6D4169Q58565558-46866660-67F6-4712-AFEB-617169122570
P2860
AMP-activated protein kinase phosphorylates cardiac troponin I and alters contractility of murine ventricular myocytes.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
AMP-activated protein kinase p ...... f murine ventricular myocytes.
@ast
AMP-activated protein kinase p ...... f murine ventricular myocytes.
@en
AMP-activated protein kinase p ...... f murine ventricular myocytes.
@nl
type
label
AMP-activated protein kinase p ...... f murine ventricular myocytes.
@ast
AMP-activated protein kinase p ...... f murine ventricular myocytes.
@en
AMP-activated protein kinase p ...... f murine ventricular myocytes.
@nl
prefLabel
AMP-activated protein kinase p ...... f murine ventricular myocytes.
@ast
AMP-activated protein kinase p ...... f murine ventricular myocytes.
@en
AMP-activated protein kinase p ...... f murine ventricular myocytes.
@nl
P2093
P50
P1433
P1476
AMP-activated protein kinase p ...... f murine ventricular myocytes.
@en
P2093
Barbara Casadei
Charles Redwood
Henrik Isackson
Jeffery W Walker
Joanna K Davies
Katalin Pinter
Mohamed Bellahcene
Raquel Sancho Solis
Yin-Hua Zhang
P304
P356
10.1161/CIRCRESAHA.111.259952
P577
2012-03-27T00:00:00Z